Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Hawkey

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Inflammopharmacology|March 24, 2004
The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteersBror Jonzon, Ingvar Bjarnason, Chris Hawkey, et al.
Annals of the Rheumatic Diseases|August 2, 2011
A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee painMichael Doherty, Chris Hawkey, Michael Goulder, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2017
Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux diseaseJames Britton, Lisa Gadeke, Laurence Lovat, et al.
Inflammatory Bowel Diseases|July 27, 2005
RDP58 is a novel and potentially effective oral therapy for ulcerative colitisSimon Travis, Lee Min Yap, Chris Hawkey, et al.
The American Journal of Gastroenterology|April 22, 2005
Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitorsChris Hawkey, Nicholas J Talley, Neville D Yeomans, et al.
BMJ Open|September 10, 2016
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART studyIsla S Mackenzie, Ian Ford, Andrew Walker, et al.
Lancet (London, England)|November 6, 2022
Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trialChris Hawkey, Anthony Avery, Carol A C Coupland, et al.
The American Journal of Gastroenterology|July 19, 2008
Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirinNeville Yeomans, Angel Lanas, Joachim Labenz, et al.
Ecancermedicalscience|March 9, 2018
Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, BerlinJaqui Walker, Pippa Hutchison, Junbo Ge, et al.
Journal of Crohn'S & Colitis|January 12, 2018
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) in Severe Crohn's Disease: A Review on Behalf of ECCO and EBMTJohn A Snowden, Julián Panés, Tobias Alexander, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Inflammopharmacology|March 24, 2004
The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteersBror Jonzon, Ingvar Bjarnason, Chris Hawkey, et al.
Annals of the Rheumatic Diseases|August 2, 2011
A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee painMichael Doherty, Chris Hawkey, Michael Goulder, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2017
Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux diseaseJames Britton, Lisa Gadeke, Laurence Lovat, et al.
Inflammatory Bowel Diseases|July 27, 2005
RDP58 is a novel and potentially effective oral therapy for ulcerative colitisSimon Travis, Lee Min Yap, Chris Hawkey, et al.
The American Journal of Gastroenterology|April 22, 2005
Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitorsChris Hawkey, Nicholas J Talley, Neville D Yeomans, et al.
BMJ Open|September 10, 2016
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART studyIsla S Mackenzie, Ian Ford, Andrew Walker, et al.
Lancet (London, England)|November 6, 2022
Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trialChris Hawkey, Anthony Avery, Carol A C Coupland, et al.
The American Journal of Gastroenterology|July 19, 2008
Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirinNeville Yeomans, Angel Lanas, Joachim Labenz, et al.
Ecancermedicalscience|March 9, 2018
Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, BerlinJaqui Walker, Pippa Hutchison, Junbo Ge, et al.
Journal of Crohn'S & Colitis|January 12, 2018
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) in Severe Crohn's Disease: A Review on Behalf of ECCO and EBMTJohn A Snowden, Julián Panés, Tobias Alexander, et al.
Pageof 2